Role of serum adiponectin level in assessment of obese patients with Barrett's esophagus | ||||
| Egyptian Journal of Cancer and Biomedical Research | ||||
| Article 5, Volume 5, Issue 4, December 2021, Page 59-72 PDF (2.7 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/jcbr.2021.80400.1214 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Ayman El Lehleh1; Manal Ellaithy2; Ahmed Zahran3; Naglaa Elabd   1
| ||||
| 1Tropical Medicine Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt | ||||
| 2Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt | ||||
| 3Hepatology and Gastroenterology Department, Shebin El-Kom Teaching Hospital, Menoufia, Egypt | ||||
| Abstract | ||||
| Background: Obesity especially visceral obesity is an important independent risk factor for the development of gastro-esophageal reflux disease (GERD) and, Barrett’s esophagus (BE). Aim: In this work, we aimed to evaluate serum adiponectin level in obese patients with GERD and Barrett's oesophagus as well as highlight its role in early predicting Barrett's oesophagus. Materials and Method: 120 participants with BMI ≥ 25 were involved in this case control study. They were grouped into Group I: 30 participants of coincided BMI, age and gender as obese controls;Group II:included 60 patients with GERD, and Group III: 30 patients with BE. All participants were subjected to clinical evaluation, Upper endoscope and serum adiponectin by ELISA. Biopsy with histopathological evaluation to confirm BE was done. Results: Significantly lower plasma adiponectin levels were detected in BE patients compared to GERD patients and the control group with significantly higher plasma adiponectin levels in GERD compared to controls. ROC analysis showed that AUC was 0.958 at a cut-off point ≤ 0.74, sensitivity and specificity were (90.0% and 95.0% respectively) for prediction of BE in GERD patients. Lower adiponectin levels were found in patients with large sliding hiatus hernia, long-segment Barrett as well as patients with high-grade dysplasia. Multivariate analysis displayed that adiponectin could be an independent predictor for BE. Conclusion: Obesity is a substantial risk for the development of GERD and BE. Adequate weight control is an important step for the prevention ofBE. Additionally, adiponectin serum levels could be a reliable non-invasive biomarker for early prediction of BE. | ||||
| Keywords | ||||
| Adiponectin; Barrett's oesophagus; GERD; obesity | ||||
|
Statistics Article View: 256 PDF Download: 135 |
||||
